Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 4291 AL 4305

The prodromes of Parkinson's disease

Rees RN, Noyce AJ, Schrag A.

Eur J Neurosci. 2019 Feb;49(3):320-327. doi: 10.1111/ejn.14269. Epub 2018 Dec 5.

Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders

Zarriello S, Tuazon JP, Corey S, Schimmel S, Rajani M, Gorsky A, Incontri D, Hammock BD, Borlongan CV.

Prog Neurobiol. 2019 Jan;172:23-39. doi: 10.1016/j.pneurobio.2018.11.001. Epub 2018 Nov 14.

Can the gut be the missing piece in uncovering PD pathogenesis?

Chapelet G, Leclair-Visonneau L, Clairembault T, Neunlist M, Derkinderen P.

Parkinsonism Relat Disord. 2019 Feb;59:26-31. doi: 10.1016/j.parkreldis.2018.11.014. Epub 2018 Nov 12.

The role of monogenic genes in idiopathic Parkinson's disease

Reed X, Bandrés-Ciga S, Blauwendraat C, Cookson MR.

Neurobiol Dis. 2019 Apr;124:230-239. doi: 10.1016/j.nbd.2018.11.012. Epub 2018 Nov 15.

Glimepiride prevents paraquat-induced Parkinsonism in mice: involvement of oxidative stress and neuroinflammation

Ishola IO, Akataobi OE, Alade AA, Adeyemi OO.

Fundam Clin Pharmacol. 2019 Jun;33(3):277-285. doi: 10.1111/fcp.12434. Epub 2018 Dec 7.

Parkinson's disease: Evolution of the scientific literature from 1983 to 2017 by countries and journals

Robert C, Wilson CS, Lipton RB, Arreto CD.

Parkinsonism Relat Disord. 2019 Apr;61:10-18. doi: 10.1016/j.parkreldis.2018.11.011. Epub 2018 Nov 10.

Progressive Supranuclear Palsy-like Syndrome from Possible Cerebral Amyloid Angiopathy

Shetty A, Camicioli R, Ba F.

Can J Neurol Sci. 2019 Jan;46(1):132-136. doi: 10.1017/cjn.2018.367. Epub 2018 Nov 20.

Age-related diseases as vicious cycles

Belikov AV.

Ageing Res Rev. 2019 Jan;49:11-26. doi: 10.1016/j.arr.2018.11.002. Epub 2018 Nov 17.

Taking the 'Disease' out of 'Parkinson's': has the disease had its day?

Worth PF.

Pract Neurol. 2019 Feb;19(1):2-4. doi: 10.1136/practneurol-2018-002066. Epub 2018 Nov 21.

Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients with Parkinsonism from Controls

Marques TM, van Rumund A, Bruinsma IB, Wessels HJCT, Gloerich J, Esselink RAJ, Bloem BR, Kuiperij HB, Verbeek MM.

Mol Neurobiol. 2019 Jul;56(7):5067-5074. doi: 10.1007/s12035-018-1426-9. Epub 2018 Nov 21.

The role of dopamine in the brain - lessons learned from Parkinson's disease

Meder D, Herz DM, Rowe JB, Lehéricy S, Siebner HR.

Neuroimage. 2019 Apr 15;190:79-93. doi: 10.1016/j.neuroimage.2018.11.021. Epub 2018 Nov 20.

Diagnostic biomarkers for Parkinson's disease: focus on α-synuclein in cerebrospinal fluid

Kalia LV.

Parkinsonism Relat Disord. 2019 Feb;59:21-25. doi: 10.1016/j.parkreldis.2018.11.016. Epub 2018 Nov 15.

Alpha-lipoic acid in the treatment of psychiatric and neurological disorders: a systematic review

de Sousa CNS, da Silva Leite CMG, da Silva Medeiros I, Vasconcelos LC, Cabral LM, Patrocínio CFV, Patrocínio MLV, Mouaffak F, Kebir O, Macedo D, Patrocínio MCA, Vasconcelos SMM.

Metab Brain Dis. 2019 Feb;34(1):39-52. doi: 10.1007/s11011-018-0344-x. Epub 2018 Nov 22.

Relationship between long non-coding RNAs and Alzheimer's disease: a systematic review

Chen L, Guo X, Li Z, He Y.

Pathol Res Pract. 2019 Jan;215(1):12-20. doi: 10.1016/j.prp.2018.11.012. Epub 2018 Nov 13.

The virtual reality of Parkinson's disease freezing of gait: A systematic review

Bluett B, Bayram E, Litvan I.

Parkinsonism Relat Disord. 2019 Apr;61:26-33. doi: 10.1016/j.parkreldis.2018.11.013. Epub 2018 Nov 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias